{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:10:37Z","timestamp":1771557037611,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.xphs.2017.10.029","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T12:43:19Z","timestamp":1509021799000},"page":"934-941","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3857-2317","authenticated-orcid":false,"given":"Cenk","family":"Daglioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2017.10.029_bib1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945011795378540","article-title":"Improving cancer chemotherapy with modulators of ABC drug transporters","volume":"12","author":"Shukla","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.xphs.2017.10.029_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drup.2011.01.003","article-title":"Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance","volume":"14","author":"Shapira","year":"2011","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.xphs.2017.10.029_bib3","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.addr.2013.09.001","article-title":"Exploiting nanotechnology to overcome tumor drug resistance: challenges and opportunities","volume":"65","author":"Kirtane","year":"2013","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.10.029_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2014.09.020","article-title":"Ros-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor\u2019s multidrug resistance","volume":"196","author":"Su","year":"2014","journal-title":"J\u00a0Control Release"},{"key":"10.1016\/j.xphs.2017.10.029_bib5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.addr.2008.03.018","article-title":"Magnetic nanoparticles in MR imaging and drug delivery","volume":"60","author":"Sun","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2017.10.029_bib6","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1002\/anie.200801810","article-title":"Micellar hybrid nanoparticles for simultaneous magneto-fluorescent imaging and drug delivery","volume":"47","author":"Park","year":"2008","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.xphs.2017.10.029_bib7","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jinorgbio.2004.07.009","article-title":"Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumors","volume":"98","author":"Russell-Jones","year":"2004","journal-title":"J\u00a0Inorg Biochem"},{"key":"10.1016\/j.xphs.2017.10.029_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.colsurfb.2017.05.012","article-title":"Enhancing tumor cell response to multidrug resistance with pH-sensitive quercetin and doxorubicin conjugated multifunctional nanoparticles","volume":"156","author":"Daglioglu","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.xphs.2017.10.029_bib9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/acs.bioconjchem.6b00080","article-title":"Synthesis and characterization of AICAR and DOX conjugated multifunctional nanoparticles as a platform for synergistic inhibition of cancer cell growth","volume":"27","author":"Daglioglu","year":"2016","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.xphs.2017.10.029_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11095-016-2053-7","article-title":"Therapeutic effects of AICAR and DOX conjugated multifunctional nanoparticles in sensitization and elimination of cancer cells via survivin targeting","volume":"34","author":"Daglioglu","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.10.029_bib11","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1124\/dmd.109.028654","article-title":"Endogenous gene and protein expression of drug-transporting proteins in cell lines routinely used in drug discovery programs","volume":"37","author":"Ahlin","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2017.10.029_bib12","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1021\/ja806519m","article-title":"pH controlled release of chromone from Chromone-Fe3O4 nanoparticles","volume":"130","author":"Wang","year":"2008","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.xphs.2017.10.029_bib13","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/cr068445e","article-title":"Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications","volume":"108","author":"Laurent","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.xphs.2017.10.029_bib14","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s11095-010-0091-0","article-title":"Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(\u03b2-L-malic acid)","volume":"27","author":"Patil","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2017.10.029_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/pr.56.2.6","article-title":"Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity","volume":"56","author":"Minotti","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.xphs.2017.10.029_bib16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1158\/1535-7163.MCT-06-0190","article-title":"The analysis of doxorubicin resistance in human breast cancer cells using antibody microarrays","volume":"5","author":"Smith","year":"2006","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917307281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917307281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T09:39:10Z","timestamp":1535276350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917307281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0022354917307281"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.10.029","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Environmentally Responsive Dual-Targeting Nanoparticles: Improving Drug Accumulation in Cancer Cells as a Way of Preventing Anticancer Drug Efflux","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}